Performance analysis of Ernexa Therapeutics (ERNA)
Annual Return
Over the past 3 years, ERNA has had an average annual return of -68.20%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, ERNA has had an average annual return of -81.84%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, ERNA has had an average annual return of -52.67%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Nov 1, 1999, ERNA has had an average annual return of -30.16%, underperforming the benchmark SPY, which returned +8.49% annual.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | -83.33% | -45.45% | -96.04% | -7.02% | +2.05% | +12.69% | -53.65% | -50.49% | +6.19% | -63.62% | -30.17% |
| 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
| +200% | -16.02% | -34.19% | -15.57% | +233.33% | -78.22% | -54.75% | -8.05% | -53.29% | -13.78% | +208.34% | +33.33% |
| 2001 | 2000 | 1999 | |||||||||
| +43.99% | -83.05% | +145.87% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +0% | +0% | +0% | +0% | +0% | +0% | +0% | ||||||
| 2024 | +0% | -16.67% | +60% | -25.00% | +0% | +0% | +0% | +0% | -33.33% | +0% | -75.00% | +0% | -83.33% |
| 2023 | +45.45% | -18.75% | -15.38% | -9.09% | -30.00% | +14.29% | +12.50% | -11.11% | -12.50% | -28.57% | -40.00% | +100% | -45.45% |
| 2022 | -34.89% | -16.57% | -9.27% | -48.91% | -35.71% | -22.22% | -8.57% | -15.63% | -40.74% | -31.25% | +0% | -0% | -96.04% |
| 2021 | +73.91% | -7.12% | -48.65% | +1,238.71% | -71.08% | +25.10% | -36.22% | +5.09% | -22.98% | -8.39% | -30.11% | -29.97% | -7.02% |
| 2020 | +1.37% | -4.38% | -28.52% | -26.60% | -0% | +96.64% | -7.51% | -11.07% | -5.81% | +5.29% | +13.81% | +9.93% | +2.05% |
| 2019 | +46.15% | +20.26% | +17.51% | -25.51% | +16.75% | +8.14% | -11.49% | -27.52% | +38.27% | -15.18% | -5.26% | -18.61% | +12.69% |
| 2018 | +33.87% | +14.11% | +5.83% | -30.76% | -12.74% | +8.03% | +2.70% | +9.21% | -10.69% | -11.80% | -41.87% | -14.47% | -53.65% |
| 2017 | -7.86% | -26.72% | +49.93% | -5.93% | -17.24% | +1.57% | -5.73% | +13.80% | -16.14% | -1.72% | -20.20% | -12.34% | -50.49% |
Drawdown analysis of Ernexa Therapeutics (ERNA)
The maximum drawdown for the ERNA was -100.00%, occurring on Nov 27, 2024. This drawdown has not yet recovered.
The current ERNA drawdown is -100.00%.
Since Nov 1, 1999 ERNA has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 4 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -100.00% | Mar 13, 2000 | 6218 | Nov 27, 2024 | Ongoing | Ongoing | Ongoing |
| -47.37% | Dec 14, 1999 | 32 | Jan 31, 2000 | 28 | Mar 10, 2000 | 60 |
| -15.15% | Nov 29, 1999 | 5 | Dec 6, 1999 | 5 | Dec 13, 1999 | 10 |
| -13.64% | Nov 8, 1999 | 1 | Nov 9, 1999 | 9 | Nov 22, 1999 | 10 |
| -8.33% | Nov 1, 1999 | 1 | Nov 2, 1999 | 2 | Nov 4, 1999 | 3 |
| -7.14% | Nov 22, 1999 | 1 | Nov 23, 1999 | 1 | Nov 24, 1999 | 2 |